SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001050007-17-000006
Filing Date
2017-01-26
Accepted
2017-01-26 15:46:00
Documents
2
Period of Report
2017-01-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nutr-012617x8k.htm 8-K 50725
2 EXHIBIT 99.1 nutr-ex991x012617.htm EX-99.1 74669
  Complete submission text file 0001050007-17-000006.txt   126790
Mailing Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060
Business Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060 4356556000
NUTRACEUTICAL INTERNATIONAL CORP (Filer) CIK: 0001050007 (see all company filings)

IRS No.: 870515089 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 000-23731 | Film No.: 17549634
SIC: 2833 Medicinal Chemicals & Botanical Products